Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 562,077 |
|
|||||
| News | - | ||||||
| Day High | 24.24 | Low High |
|||||
| Day Low | 23.305 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Rocket Pharmaceuticals Inc | RCKT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.17 | -0.72% | 23.50 | 15:10:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 23.87 | 23.305 | 24.24 | 23.67 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,455 | 562,077 | $ 23.64 | $ 13,287,583 | - | 14.89 - 32.525 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:11:55 | 1 | $ 23.4967 | USD |
Rocket Pharmaceuticals (RCKT) Options Flow Summary
Rocket Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.15M | 90.50M | - | 0 | -245.6M | -2.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Rocket Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RCKT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.51 | 24.76 | 22.32 | 23.41 | 634,979 | -1.01 | -4.12% |
| 1 Month | 26.36 | 27.295 | 22.32 | 24.70 | 629,657 | -2.86 | -10.85% |
| 3 Months | 28.89 | 31.47 | 22.32 | 27.39 | 721,904 | -5.39 | -18.66% |
| 6 Months | 17.90 | 32.525 | 17.38 | 25.93 | 803,126 | 5.60 | 31.28% |
| 1 Year | 18.43 | 32.525 | 14.89 | 22.87 | 872,530 | 5.07 | 27.51% |
| 3 Years | 45.08 | 49.66 | 7.565 | 21.31 | 740,875 | -21.58 | -47.87% |
| 5 Years | 19.26 | 67.48 | 7.565 | 23.83 | 598,699 | 4.24 | 22.01% |
Rocket Pharmaceuticals Description
| Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. |
